Knight Therapeutics Inc

Entity: Company
Business address: 3400 Boulevard De Maisonneuve West, Suite 1055, H3Z 3B8 Montreal, Quebec, Canada
Phone: 5144844483
State of incorporation: Quebec, Canada
Fiscal year end: December 31
13D/G Schedule signature: KNIGHT THERAPEUTICS INC. - Samira Sakhia / President and Chief Executive Officer
Insider ownership signature: /s/ Samira Sakhia
All SEC filings: View on sec.gov

⭐ Add to watchlist ⭐

Get insider transactions for this reporting owner

Knight Therapeutics Inc has filed 9 SEC EDGAR filings since 10/17/2018

Latest Filings

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
SCHEDULE 13G/A	Open Document	Open Filing		Jun 13, 2025
4	Open Document	Open Filing		Jun 13, 2025	Jun 11, 2025	001-42374
SCHEDULE 13G	Open Document	Open Filing		Mar 20, 2025
SC 13G/A	Open Document	Open Filing	AMENDMENT NO. 2 TO SCHEDULE 13G	Nov 13, 2024
3	Open Document	Open Filing	PRIMARY DOCUMENT	Oct 22, 2024	Oct 22, 2024	001-42374
4	Open Document	Open Filing	FORM 4	Apr 3, 2024	Jul 28, 2023	001-41719
3	Open Document	Open Filing		Dec 18, 2023	Jul 11, 2023	001-41719
SC 13G/A	Open Document	Open Filing	SC 13G/A	Feb 14, 2019
SC 13G	Open Document	Open Filing	SCHEDULE 13G	Oct 17, 2018